Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.
about
Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Absent and abundant MET immuno ...... ngeal squamous cell carcinoma.
@en
Absent and abundant MET immuno ...... ngeal squamous cell carcinoma.
@nl
type
label
Absent and abundant MET immuno ...... ngeal squamous cell carcinoma.
@en
Absent and abundant MET immuno ...... ngeal squamous cell carcinoma.
@nl
prefLabel
Absent and abundant MET immuno ...... ngeal squamous cell carcinoma.
@en
Absent and abundant MET immuno ...... ngeal squamous cell carcinoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Absent and abundant MET immuno ...... ngeal squamous cell carcinoma.
@en
P2093
Berdine van der Steen
Geert J L H van Leenders
Maria J De Herdt
Rob Noorlag
Robert J J van Es
Senada KoljenoviÄ
Stefan M Willems
P2860
P304
13167-13181
P356
10.18632/ONCOTARGET.7534
P407
P577
2016-02-20T00:00:00Z